logo

Seattle Genetics Inc. (SGEN)



Trade SGEN now with
  Date
  Headline
10/30/2020 10:06:54 AM Stock Alert: Seagen Tumbles 9%
10/29/2020 4:13:12 PM Seagen Q3 EPS $3.50 Vs. Loss $0.55 Year Ago
10/28/2020 8:04:58 AM Seagen Reports Closing Of $1.0 Bln Stock Sale To Merck
10/12/2020 6:51:09 AM Astellas, Seagen Announce Positive Topline Results From Second Cohort Of Patients In Phase 2 Pivotal Trial Of PADCEV
10/8/2020 8:03:51 AM Seattle Genetics, Inc. Changes Corporate Name To Seagen Inc.; Ticker Symbol To Continue Under "SGEN"
9/21/2020 10:26:22 AM Seattle, Genmab Present Data From Tisotumab Vedotin InnovaTV 204 Trial In Recurrent Or Metastatic Cervical Cancer
9/18/2020 6:51:03 AM Seattle Genetics And Astellas Pharma Announce Phase 3 Trial Of PADCEV Meets Primary Endpoint
9/14/2020 6:52:01 AM Seattle Genetics, Merck Announce Strategic Oncology Collaborations; Merck To Buy $1 Bln Equity Stake In Seattle Genetics
8/27/2020 8:13:26 AM Seattle Genetics To Receive Milestone Payment From GlaxoSmithKline Under ADC Collaboration
8/27/2020 8:09:06 AM Seattle Genetics Highlights Data From Broad Oncology Portfolio During ESMO Virtual Congress 2020
8/12/2020 8:05:51 AM Seattle Genetics Says TUKYSA Approved Within Months For All Countries Participating In FDA's Project Orbis Initiative
7/30/2020 4:06:22 PM Seattle Genetics Q2 Loss/share $0.12 Vs. Loss $0.49 Year Ago